Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 3 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 3

From: "Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)

Fig. 3

A 55-year-old female patient with negative past medical history and had received “Sinopharm” vaccine then got COVID-19 infection. A, B Axial chest CT cuts (lung window) showed bilateral mainly peripheral located ground-glass pneumonic patches with peripheral sub-pleural sparing (Atol-sign). C CT-Volumetry of the pathological lung parts averages 830 cc. D CT-Volumetry of total lung volume averages 2568 cc. So, 32% of the lung parenchyma was diseased (Score 2)

Back to article page